Filing Details
- Accession Number:
- 0001061983-17-000057
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-08 16:48:13
- Reporting Period:
- 2017-09-06
- Accepted Time:
- 2017-09-08 16:48:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1061983 | Cytokinetics Inc | CYTK | Pharmaceutical Preparations (2834) | 943291317 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1674232 | Gordon Caryn Mcdowell | 280 East Grand Avenue South San Francisco CA 94080 | Gc & Chief Compliance Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-09-06 | 100 | $15.00 | 18,369 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2017-09-06 | 5,732 | $0.00 | 5,732 | $6.37 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2017-09-06 | 3,067 | $0.00 | 3,067 | $6.67 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-09-06 | 1,432 | $0.00 | 1,432 | $6.67 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 18,857 | 2016-05-29 | 2025-05-29 | No | 4 | M | Direct |
| 23,715 | 2016-03-23 | 2026-02-23 | No | 4 | M | Direct |
| 2,659 | 2016-03-23 | 2026-02-23 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017.
Billionaire Hedge Funds
